F
Francesco d'Amore
Researcher at Aarhus University Hospital
Publications - 169
Citations - 8244
Francesco d'Amore is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Lymphoma & Population. The author has an hindex of 36, co-authored 169 publications receiving 6861 citations. Previous affiliations of Francesco d'Amore include Aarhus University & University of Nebraska Medical Center.
Papers
More filters
Journal ArticleDOI
Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
Andrea Gallamini,Martin Hutchings,Luigi Rigacci,Lena Specht,Francesco Merli,Mads Hansen,Caterina Patti,Annika Loft,Francesco Di Raimondo,Francesco d'Amore,Alberto Biggi,Umberto Vitolo,Caterina Stelitano,R Sancetta,Livio Trentin,Stefano Luminari,Emilio Iannitto,Simonetta Viviani,Ivana Pierri,Alessandro Levis +19 more
TL;DR: PET-2 overshadows the prognostic value of IPS and emerges as the single most important tool for planning of risk-adapted treatment in advanced HL.
Journal ArticleDOI
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
Martin Hutchings,Annika Loft,Annika Loft,Mads Hansen,Mads Hansen,Lars Møller Pedersen,Lars Møller Pedersen,Thora Buhl,Thora Buhl,Jesper Jurlander,Jesper Jurlander,Simon Buus,Simon Buus,Susanne Keiding,Susanne Keiding,Francesco d'Amore,Francesco d'Amore,Anne-Marie Boesen,Anne-Marie Boesen,Anne Kiil Berthelsen,Anne Kiil Berthelsen,Lena Specht,Lena Specht +22 more
TL;DR: For prediction of PFS, interim FDG-PET was as accurate after two cycles as later during treatment and superior to computerized tomography (CT) at all times and in regression analyses, early interimFDG- PET was stronger than established prognostic factors.
Journal ArticleDOI
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
Peter Johnson,Massimo Federico,Amy A Kirkwood,Alexander Fosså,Leanne Berkahn,Angelo Michele Carella,Francesco d'Amore,Gunilla Enblad,Antonella Franceschetto,Michael J. Fulham,Stefano Luminari,Michael O'Doherty,Pip Patrick,Thomas Roberts,Gamal Sidra,L. Stevens,Paul Smith,Judith Trotman,Z. Viney,John Radford,Sally F. Barrington +20 more
TL;DR: Although the results fall just short of the specified noninferiority margin, the omission of bleomycin from the ABVD regimen after negative findings on interim PET resulted in a lower incidence of pulmonary toxic effects than with continued ABVD but not significantly lower efficacy.
Journal ArticleDOI
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
A. Z. S. Rohatiner,Francesco d'Amore,B Coiffier,Derek Crowther,Mary Gospodarowicz,Peter G. Isaacson,T. A. Lister,A. Norton,P Salem,Margaret A. Shipp +9 more
TL;DR: The following recommendations were made: to adopt the Isaacson histological classification, that all patients with GI tract lymphoma be investigated uniformly, to record the prognostic factors described above.
Journal ArticleDOI
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
Francesco d'Amore,Thomas Relander,Grete F. Lauritzsen,Esa Jantunen,Hans Hagberg,Harald Anderson,Harald Holte,Anders Österborg,Mats Merup,Peter de Nully Brown,Outi Kuittinen,Martin Erlanson,Bjørn Østenstad,Unn-Merete Fagerli,Ole V. Gadeberg,Christer Sundström,Jan Delabie,Elisabeth Ralfkiaer,Martine Vornanen,Helle Toldbod +19 more
TL;DR: Dose-dense induction followed by HDT/ASCT was well tolerated and led to long-term PFS in 44% of treatment-naive patients with PTCL, which represents an encouraging outcome, particularly considering the high median age and adverse risk profile of the study population.